Peak Gastroenterology Associates, PC

Clinical research site in Colorado Springs, Colorado · 595 CHAPEL HILLS DR STE 303, COLORADO SPRINGS, CO 80920-1057 · (719) 636-1201 · Website

As of July 2026, 28 paid clinical trials are recruiting at Peak Gastroenterology Associates, PC in Colorado Springs, Colorado. Active studies at this site cover conditions such as Ulcerative Colitis, Crohn Disease and Colitis, Ulcerative. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Peak Gastroenterology Associates, PC (28)

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

for Crohn Disease

24 locations incl. Dothan

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07499232·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

for Ulcerative Colitis (UC)

50 locations incl. Phoenix

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 80

Code: NCT07415044·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)

for Liver Cirrhosis

26 locations incl. Chandler

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18 - 75

Code: NCT07325526·Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for Crohn's Disease

94 locations incl. Peoria

Sponsor: Sanofi

Sex: All·Age: 16 - 80

Code: NCT07184931·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

for Ulcerative Colitis

40 locations incl. Scottsdale

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 80

Code: NCT07186101·Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

for Crohn Disease

55 locations incl. Chandler

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07196722·Phase 2, Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

for Colitis, Ulcerative

51 locations incl. Chandler

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 12+

Code: NCT07196748·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for Ulcerative Colitis

28 locations incl. Tucson

Sponsor: Sanofi

Sex: All·Age: 16 - 80

Code: NCT07185009·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for Ulcerative Colitis

91 locations incl. Peoria

Sponsor: Sanofi

Sex: All·Age: 16 - 80

Code: NCT07184996·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

for Crohn's Disease

71 locations incl. Sun City

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 16 - 80

Code: NCT06430801·Phase 3·Recruiting·Listed May 2024

Apply to this trial

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

for Ulcerative Colitis

76 locations incl. Birmingham

Sponsor: Takeda

Sex: All·Age: 18 - 80

Code: NCT06581328·Phase 4·Recruiting·Listed Sep 2024

Apply to this trial

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for Moderately to Severely Active Crohns Disease

52 locations incl. Glendale

Sponsor: Hoffmann-La Roche

Sex: All·Age: 16 - 80

Code: NCT06819891·Phase 3·Recruiting·Listed Feb 2025

Apply to this trial

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

for Moderately to Severely Active Ulcerative Colitis

70 locations incl. Dothan

Sponsor: Hoffmann-La Roche

Sex: All·Age: 16 - 80

Code: NCT06588855·Phase 3·Recruiting·Listed Sep 2024

Apply to this trial

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

for Inflammatory Bowel Diseases

25 locations incl. Lancaster

Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

Sex: All·Age: 18 - 85

Code: NCT06226883·Phase 2·Recruiting·Listed Jan 2024

Apply to this trial

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

for Primary Biliary Cholangitis (PBC)

31 locations incl. Tucson

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT06016842·Phase 3·Recruiting·Listed Aug 2023

Apply to this trial

Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

for Alpha1-Antitrypsin Deficiency

33 locations incl. Birmingham

Sponsor: Takeda

Sex: All·Age: 18 - 75

Code: NCT05677971·Phase 3·Recruiting·Listed Jan 2023

Apply to this trial

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

for Moderately to Severely Active Crohn Disease

43 locations incl. Fairhope

Sponsor: Abivax S.A.

Sex: All·Age: 18 - 75

Code: NCT06456593·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

for Ulcerative Colitis

46 locations incl. Chandler

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 75

Code: NCT06598943·Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for Crohn's Disease

22 locations incl. Colorado Springs

Sponsor: Sanofi

Sex: All·Age: 16 - 80

Code: NCT07184944·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

VTP-1000 in Adults With Celiac Disease

for Celiac Disease

16 locations incl. Los Angeles

Sponsor: Barinthus Biotherapeutics

Sex: All·Age: 18 - 70

Code: NCT06310291·EARLY_Phase 1·Recruiting·Listed Mar 2024

Apply to this trial

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

for Ulcerative Colitis

14 locations incl. Scottsdale

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18 - 80

Code: NCT06636656·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

for Crohn's Disease

9 locations incl. La Jolla

Sponsor: Takeda

Sex: All·Age: 18 - 65

Code: NCT06227910·Phase 3·Recruiting·Listed Jan 2024

Apply to this trial

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

for Alpha1-Antitrypsin Deficiency

20 locations incl. Phoenix

Sponsor: Takeda

Sex: All·Age: 18 - 75

Code: NCT06165341·Phase 3·Recruiting·Listed Dec 2023

Apply to this trial

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

for Crohn Disease

6 locations incl. Anaheim

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07577843·Phase 3·Recruiting·Listed May 2026

Apply to this trial

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

for Colitis, Ulcerative

7 locations incl. Anaheim

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07577856·Phase 3·Recruiting·Listed May 2026

Apply to this trial

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

for Colitis Ulcerative

9 locations incl. Anaheim

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18 - 75

Code: NCT07463183·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis

for Primary Sclerosing Cholangitis

4 locations incl. Chandler

Sponsor: Ipsen

Sex: All·Age: 18 - 75

Code: NCT07387549·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

for Ulcerative Colitis

8 locations incl. Lancaster

Sponsor: Genentech, Inc.

Sex: All·Age: 18+

Code: NCT06979336·Phase 2·Recruiting·Listed May 2025

Apply to this trial

More research sites in Colorado Springs

UCHealth Memorial Hospital Central (32 trials)
Rocky Mountain Cancer Centers-Penrose (30 trials)
Memorial Hospital North (29 trials)
Penrose-Saint Francis Healthcare (29 trials)
Saint Francis Cancer Center (28 trials)
Peak Gastroenterology Associates (22 trials)
Retina Consultants of Southern Colorado (7 trials)
Colorado ENT & Allergy (6 trials)
Rocky Mountain Cancer Centers, LLP (4 trials)
Asthma and Allergy Associates, PC (4 trials)

Explore more

Paid clinical trials in Colorado Springs, CO · Colorado clinical trials